Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on May 26, 2015, covering events occurring on May 21, 2015. The filing addresses executive leadership changes and provides an update on full-year financial guidance.
Key Financial Metrics
The filing does not report specific revenue, profit, cash flow, margin, debt, or liquidity figures for a completed period. Instead, it provides forward-looking earnings guidance for the full year 2015:
- Full Year 2015 Net Income Guidance: Greater than $9.47 per share.
- Unfavorable Items: Includes greater than $0.43 per share of net unfavorable items.
- Adjusted Net Income Guidance: Greater than $9.90 per share (excluding the unfavorable items).
Material Changes
Executive Departure: Kenneth R. Goulet, Executive Vice President and President of the Commercial and Specialty Business, notified the company on May 21, 2015, of his retirement later in the summer. The departure is attributed to personal reasons with no disagreement with the company. Mr. Goulet will remain in his role for a few months to facilitate a transition.
Guidance Reaffirmation: The company reaffirmed its 2015 net income guidance, noting no additional net adjustment items beyond those reported in the first quarter 2015 earnings release.
Outlook, Risks, and Management Commentary
Management has confirmed that the full-year 2015 outlook remains stable with no new adjustment items anticipated. The filing explicitly states that the information regarding guidance is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the exact date of Kenneth R. Goulet's retirement and the identity of his successor once named.
- Confirm the specific nature of the "$0.43 per share" net unfavorable items referenced in the guidance.
- Review the attached press release (Exhibit 99.1) for any additional context on the Commercial and Specialty Business transition.
- Monitor future filings for the official appointment of Mr. Goulet's replacement.